Tcr2 Therapeutics Inc.

Tower Research Capital LLC (TRC)

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/9/2023

Shares

7,678

Value ($000)

11

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/9/2023	11	0.0%	7,678	3/31/2023
2022 Q4	2/10/2023	7	0.0%	6,937	12/31/2022
2022 Q3	11/10/2022	7	0.0%	3,759	9/30/2022
2022 Q2	8/15/2022	19	0.0%	6,727	6/30/2022
2022 Q1	5/12/2022	27	0.0%	9,696	3/31/2022
2021 Q4	2/14/2022	81	0.0%	17,438	12/31/2021
2021 Q3	11/15/2021	66	0.0%	7,753	9/30/2021
2021 Q2	8/16/2021	44	0.0%	2,692	6/30/2021
2021 Q1	5/17/2021	50	0.0%	2,267	3/31/2021
2020 Q4	2/16/2021	28	0.0%	920	12/31/2020
2020 Q3	11/16/2020	376	0.0%	18,528	9/30/2020
2020 Q2	8/13/2020	38	0.0%	2,499	6/30/2020
2020 Q1	5/15/2020	15	0.0%	1,955	3/31/2020
2019 Q4	2/7/2020	34	0.0%	2,371	12/31/2019